Tensor Based Tumor Tissue Type Differentiation Using Magnetic Resonance Spectroscopic Imaging by Halandur Nagaraja, Bharath et al.
Tensor Based Tumor Tissue Type Differentiation Using Magnetic
Resonance Spectroscopic Imaging
H. N. Bharath1,2, D. M. Sima1,2, N. Sauwen1,2, U. Himmelreich3, L. De Lathauwer1,4, S. Van Huffel1,2
Abstract— Magnetic resonance spectroscopic imaging
(MRSI) has the potential to characterise different tissue types
in brain tumors. Blind source separation techniques are used
to extract the specific tissue profiles and their corresponding
distribution from the MRSI data. A 3-dimensional MRSI
tensor is constructed from in vivo 2D-MRSI data of individual
tumor patients. Non-negative canonical polyadic decomposition
(NCPD) with common factor in mode-1 and mode-2 and l1
regularization on mode-3 is applied on the MRSI tensor to
differentiate various tissue types. Initial in vivo study shows
that NCPD has better performance in identifying tumor and
necrotic tissue type in high grade glioma patients compared to
previous matrix-based decompositions, such as non-negative
matrix factorization and hierarchical non-negative matrix
factorization.
I. INTRODUCTION
Accurate characterisation and localization of pathologic
tissue types play a key role in diagnosis and treatment
planning of brain tumors. The tumor region of glioblastoma
multiforme (GBM) could consist of several tissue types,
which represent actively growing tumor, necrosis or normal
brain tissue [1]. In recent years, many MR modalities are
being used for tumor diagnosis [2]. Magnetic resonance
spectroscopic imaging (MRSI) is a noninvasive imaging
technique which provides spectral profiles in a two or three
dimensional voxel grid, from which the spatial distribution
of metabolite concentrations can be estimated. MRSI has
been successfully applied to diagnosis and prognosis of
brain tumors. There are many algorithms for MRSI data
analysis available in the literature that aim at tissue char-
acterisation, tumor localization and classification. An inde-
pendent component analysis based method was presented
in [3], while canonical correlation analysis was used for
tissue segmentation in [4]. Hierarchical non-negative matrix
factorization (hNMF) has been applied to brain MRSI data
to differentiate different tissue patterns in GBM patients [1].
The performance of hNMF [1] deteriorates in the presence
of artifacts because it can handle only three tissue types.
In this paper, a tensor based algorithm is proposed for
tissue type differentiation in tumor patients from 2D-MRSI
*This research was supported by ERC Advanced Grant, #339804
BIOTENSORS. This paper reflects only the authors views and the Union
is not liable for any use that may be made of the contained information.
1Department of Electrical Engineering (ESAT), STADIUS Center for
Dynamical Systems, Signal Processing and Data Analytics, KU Leuven,
Leuven, Belgium.
2iMinds Medical Information Technologies, Leuven, Belgium.
3Biomedical MRI Unit/Molecular Small Animal Imaging Center, Depart-
ment of Imaging and Pathology, KU Leuven, Leuven, Belgium.
4The Group of Science, Engineering and Technology, KU Leuven Kulak,
Kortrijk, Belgium.
signals. The proposed method consists of representing the
2D-MRSI signals in a 3-dimensional tensor and apply-
ing non-negative canonical polyadic decomposition (NCPD)
with l1 regularization to the MRSI tensor. Preliminary results
of the proposed algorithm on the in vivo study are presented
in section IV. Performance of the NCPD algorithm was
evaluated using expert labeling and compared with single-
stage NMF and hNMF.
II. MATERIALS
A. Data acquisition protocol
Short-TE MRSI data from nine patients were acquired on
a 3T MR scanner (Achieva, Philips, Best, The Netherlands)
at the University Hospital of Leuven. Point-resolved spec-
troscopy (PRESS) was used as the volume selection tech-
nique, TR/TE: 2000/35 ms, FOV: 16cm*16 cm, volume of
interest (VOI): 8cm*8cm, acquisition voxel size: 1cm*1cm,
slice thickness: 1cm. The study and the experimental proce-
dures involving human subjects have been approved by the
ethical committee of the institute.
B. Data processing
The residual water component was removed from the
MRSI data using Hankel Lanczos singular value decompo-
sition with partial reorthogonalization (HLSVD-PRO) [5].
A model order of 30 and a passband of 0.25 to 4.2 parts
per million (ppm) was used in HLSVD-PRO algorithm.
After removing the water component baseline correction and
baseline offset correction was performed. Pre-processing was
done using the Matlab based in-house software, SPID [6].
The spectra were aligned in frequency using a simulated
reference spectrum, where the reference spectrum was gen-
erated using the parameters given in [7]. The pre-processed
spectra were truncated to the region 0.25-4.2 ppm and the
truncated spectra were normalized to unit norm (l2). Voxels
outside the MRSI PRESS excitation volume are excluded
from the analysis.
III. TENSOR CONSTRUCTION AND NON-NEGATIVE CPD
A. MRSI tensor construction
For each voxel in the MRSI grid, a reduced spectrum X is
constructed from the corresponding pre-processed spectrum.
Elements of the vector X are obtained by moving an over-
lapping window over the spectrum, where the ith element of
X is the sum of squares of all the elements in the ith window
segment,
X(i) =
L
∑
j=1
s2i j (1)
si is the spectrum at the ith segment and L is the length
of the window segment. Fig. 1a shows the construction of
vector X from the spectrum. The resulting vector X can be
considered as a denoised and reduced-length version of the
original spectrum. The window length L is chosen such that
it covers the widest peak in the spectra. Use of vector X has
two advantages:
1) It reduces the length of spectra without losing vital
information required for tumor tissue type differentia-
tion.
2) It gives more weight to the peaks and makes the signal
smoother.
Fig. 1: (a) Construction of reduced spectrum, X from the pre-
processed spectra. SOS: sum of squares. (b) Construction of
the MRSI tensor T from the reduced spectra, X . n is the
number of voxels.
A 3-way MRSI tensor T is constructed by stacking XXT
from all the voxels in the MRSI grid as shown in Fig. 1(b).
B. Non-Negative CPD
Non-negative canonical polyadic decomposition (NCPD)
is a tensor decomposition method, where the tensor is de-
composed into a sum of rank-one tensors with non-negativity
constraints on the factor matrices [8]. For a third-order tensor
X ∈ RI×J×K , NCPD can be written as
X ≈ JABCK≡ R∑
r=1
ar ◦br ◦ cr, A,B,C ≥ 0 (2)
where A = [a1,a2, ...,aR] ∈ RI×R+ , B = [b1,b2, ...,bR] ∈ RJ×R+
and C= [c1,c2, ...,cR] ∈RK×R+ are non-negative factor matri-
ces. R is the rank, defined as the number of rank-one terms,
’◦’ represents outer product.
In the MRSI tensor T , the frontal slices are symmetrical,
therefore we constrain the frontal slices of each NCPD rank-
one term to be symmetric. To maintain symmetry, a common
factor matrix is used for mode-1 and mode-2 in the NCPD
as shown in Fig 2. After performing the NCPD on the MRSI
tensor T we obtain two factor matrices S and H, where S
represents the tissue specific patterns of the reduced spectra
and H represents the spatial distribution of each tissue type.
Each rank-one term obtained from the NCPD of the MRSI
tensor T corresponds to a particular tissue type. Here, we
assume that spectra corresponding to each voxel belong to a
Fig. 2: Non-negative CPD of MRSI tensor T : MRSI tensor
T is decomposed into R rank-1 tensors. Common factor S is
used in mode-1 and mode-2 to maintain symmetry of frontal
slices. Each si gives a tissue specific reduced spectral pattern
and the corresponding hi gives the spatial distribution of the
respective tissue type. Non-negativity of S and H is imposed
in the decomposition.
particular tissue type, therefore the factor matrix H will be
sparse, meaning that each row has only one high value. The
sparsity in the factor matrix H is achieved by imposing a l1
regularization on H. The NCPD with l1 regularization can
be written as
[S∗,H∗] = min
S≥0,H≥0
‖T −
R
∑
i=1
S(:, i)◦S(:, i)◦H(:, i)‖22
+λ‖Vec(H)‖1 (3)
where S and H are the aforementioned factor matrices
and λ is the parameter which controls the sparsity. In this
work, the tensor decomposition was performed using the
Tensorlab Matlab package [9]. Non-negativity constraints
and l1 regularization are applied using the structured data
fusion method [10] available in Tensorlab.
C. Recovering spectra from NCPD
The NCPD of the MRSI tensor T gives the factor matrix
S, which contains the reduced spectral patterns specific
to different tissue types. However, it is also possible to
recover tissue specific spectral sources as vectors of the
same length as the pre-processed MRSI spectra, which are
more interpretable since they can be directly compared to
the original spectra. To this end, a least squares problem
is solved, and the spectral sources representing the tissue
specific spectral pattern W are:
W = (H†Y T )T (4)
where H† is the Moore-Penrose pseudoinverse of the NCPD
factor matrix H and Y is the matrix containing the unit
normalized spectra from all voxels as its columns. The matrix
H is obtained from NCPD and it is based on the normal-
ized spectra. The distribution of the sources in the original
unnormalised spectra are more meaningful and represents
true distributions. Therefore, spatial distribution HD of the
different tissue types in the MRSI grid are obtained from
unnormalised spectra and the spectral source W using non-
negative least squares with l1 regularization [11]. Tissue
distribution maps are obtained by reshaping the rows of HD
to the 2D-MRSI grid.
IV. EXPERIMENTAL RESULTS
The proposed NCPD algorithm is applied on in vivo 1H
MRSI data of high grade glioma patients. For each patient,
all MRSI voxels have been labeled after visual inspection
by an expert; the labeling consists of an assignment of each
voxel to a tissue type (active tumor, necrosis, normal tissue,
or a mixture). The performance evaluation of the algorithms
on the in vivo study is analyzed using two measures. 1)
Source correlation: the correlation between the estimated
spectral sources and the tissue specific spectrum based on
expert labeling of the in vivo MRSI voxels is calculated [1].
The tissue specific spectrum based on expert labeling for a
particular tissue type is computed as the average of all the
spectra from the voxels labelled by the expert as belonging
to that tissue type. 2) Distribution correlation: the correlation
between the estimated distribution map corresponding to a
particular tissue type and the distribution map based on ex-
pert labeling is calculated. For each tissue type, a distribution
map based on expert labeling is obtained by using values
equal to the l2 norm of the corresponding spectra for all
voxels labeled as a certain tissue class, and values of 0 for
the other voxels.
In order to evaluate performance, three algorithms, NCPD,
single stage NMF and hNMF [1] were applied on 10 in vivo
1H MRSI datasets from 9 patients with high grade glioma.
For all the datasets, rank of R= 6 is used in NCPD and NMF
methods. Rank R= 6 is chosen based on the prior knowledge
and visual inspection of the results. Automatic rank selection
is still an open problem and needs to be explored through
further research. TABLE I gives the spectral correlation and
distribution correlation obtained from three algorithms for
tumor and necrosis tissue types. From TABLE I, we can see
for some datasets NMF and hNMF methods are unable to
identify the tumor source, whereas NCPD methods succeeds
in identifying tumor source and its distribution. In case of
necrotic tissue the source correlation is almost identical for
all three methods, whereas the NCPD has slightly better
distribution correlation. Moreover, in case of tumor tissue,
NCPD clearly has better source and distribution correlation
compared to NMF and hNMF.
The result of one in-vivo example is shown in Fig. 3.
NCPD, NMF and hNMF methods are applied to a 16× 16
voxel grid shown in second row of Fig. 3a. The spectra
truncated to the region 0.25-4.2 ppm are of length 517.
The reduced spectra are constructed using a window length
L= 20 and the window is moved by a stepsize of 5 samples.
Therefore the size of the MRSI tensor T with 16×16 (256)
voxels is 100×100×256. The six sources and their corre-
sponding distribution maps obtained using rank-6 NCPD and
NMF methods are shown in Fig. 3b, 3c, 3d and 3e. With the
hNMF method, only three sources are obtained, as shown
in Fig. 3f and 3g. Fig. 3g shows that the hNMF method
identifies the normal and necrotic tissue properly, but fails to
recover the tumor tissue. Single-stage NMF identifies normal
and necrotic tissue, but only the necrotic source is good and
the normal source deviates a lot as shown in Fig. 3d (1st row).
TABLE I: First two columns: in vivo MRSI datasets and
the relevant tissue type corresponding to the dataset. T and
N represent tumor and necrosis, respectively. Columns 3 to
5 give the spectral correlations for NCPD, NMF and hNMF
algorithms, respectively. Columns 6 to 8 give the distribution
correlations. ’X’ denotes failure to recover corresponding
tissue source. Last four rows show the median and median
absolute deviation (MAD) over all datasets for tumor and
necrosis, respectively.
Spectral correlation Distribution correlation
NCPD NMF hNMF NCPD NMF hNMF
1 T 0.9917 0.6592 0.7423 0.7743 0.7057 0.7015N 0.9951 0.9900 0.9964 0.8965 0.8486 0.8585
2 T 0.9622 0.6110 0.9551 0.7879 0.6695 0.6908N 0.9995 0.9974 0.9979 0.8947 0.8363 0.8779
3 T 0.9911 X X 0.8018 X XN 0.9975 0.9971 0.9972 0.9552 0.8949 0.8967
4 T 0.9918 0.5045 0.4481 0.8478 0.5117 0.5785N 0.9963 0.9902 0.9962 0.8413 0.7389 0.7433
5 T 0.9530 X X 0.6152 X XN 0.9959 0.9937 0.9901 0.8538 0.4977 0.5949
6 T 0.9809 0.6353 0.7618 0.7932 0.7990 0.7892N 0.9985 0.9952 0.9970 0.8133 0.7162 0.7346
7 T 0.9352 0.7122 0.8515 0.7047 0.6115 0.5672
8 T 0.9756 0.8805 0.9429 0.8505 0.7813 0.6429
9 T 0.9795 0.8535 0.9748 0.8967 0.8670 0.7995
10 T 0.9895 0.6899 0.8923 0.7718 0.6658 0.6969
Median(T) 0.9802 0.6745 0.8719 0.7906 0.6876 0.6938
MAD(T) 0.0112 0.0514 0.0930 0.0380 0.0849 0.0731
Median(N) 0.9969 0.9945 0.9967 0.8742 0.7876 0.8009
MAD(N) 0.0013 0.0028 0.0005 0.0276 0.0662 0.0716
NMF also fails to recover the tumor tissue. NCPD method
identifies all three, tumor, necrotic and normal tissue types.
Fig. 3b and 3c show that the estimated tissue sources and
their corresponding spatial distributions are accurate when
compared to expert labeling. In this example we estimate
six sources and their corresponding distribution from rank-
6 NCPD. Three sources correspond to tumor, necrosis and
normal tissue type, the other three sources correspond to
artifacts (Fig. 3b and 3c: 6th row) and spectra from the outer
edges of the voxel grid (Fig. 3b and 3c: 3rd and 4th row), in
other words, spectra of poor quality.
V. DISCUSSION AND CONCLUSION
In this paper we have proposed a method to represent
the 2D-MRSI data in a tensor using a reduced format of
the spectra. A novel tissue type differentiation algorithm
based on non-negative canonical polyadic decomposition
with l1 regularization was developed. To explore the clinical
applicability of the proposed algorithm, it has been tested
on 10 short-TE MRSI signals from patients having glioma.
NCPD algorithm outperforms the existing tissue type differ-
entiation methods based on NMF and hNMF. The advantage
of this tensor method is that the construction of MRSI tensor
couples the peaks in the spectra because of the XXT in
the frontal slices. Therefore, in the spectral sources obtained
from the NCPD algorithm the peaks will be coupled, i.e. we
Fig. 3: Tissue pattern differentiation using 1H MRSI: C, T and N represent normal, tumor and necrosis, respectively. (a)
First row: T2-weighted anatomical MR image of a brain tumor with areas of necrosis. Second row: voxels within the MRSI
excitation volume superimposed on anatomical image. Third row: expert labeling, where yellow indicates N, red indicates
T, magenta indicates T/N, dark blue indicates C, light blue indicates C/T and green indicates spectra of poor quality. (b, c)
results of NCPD. (b) The recovered sources from NCPD method are shown in black. First three rows represent C, N and
T spectral sources in black, with tissue specific spectra based on expert labeling overlaid in red. The remaining three rows
represent artifacts and spectra from outer edges. (c) Distribution maps corresponding to spectral profiles in (b). (d, e) Results
of single-stage NMF. (d) The recovered sources are shown in black, overlaid with the expert-based tissue specific spectra in
red. First two rows show control and necrosis spectra and the remaining rows show other spectra obtained using rank-6 NMF.
(e) Distribution maps corresponding to (d). (f, g) Results of hNMF. (f) Recovered sources shown in black and expert-based
tissue specific spectra in red. First two rows show control and tumor spectra. (g) Distribution maps corresponding to (f).
will not get individual peaks as sources. The performance
of the hNMF is not so good because the voxels in the
outer edge of MRSI excitation volume are included in the
assessment, whereas NCPD can account for artifacts and
bad voxels present in the outer edges because more sources
(R= 6) are used in the decomposition. NCPD algorithm has
the potential to replace the hNMF method in unsupervised
nosologic imaging for brain tumors [12], which can be used
as a tool to assist brain tumor diagnosis.
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